Cargando…
Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer
BACKGROUND: Exploratory biomarker analysis was conducted to identify factors related to the outcomes of patients with stage II/III gastric cancer using data from the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer, which was a randomized controlled study comparing the administration of an oral...
Autores principales: | Ichikawa, Wataru, Terashima, Masanori, Ochiai, Atsushi, Kitada, Koji, Kurahashi, Issei, Sakuramoto, Shinichi, Katai, Hitoshi, Sano, Takeshi, Imamura, Hiroshi, Sasako, Mitsuru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321694/ https://www.ncbi.nlm.nih.gov/pubmed/26884344 http://dx.doi.org/10.1007/s10120-016-0600-x |
Ejemplares similares
-
TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study
por: Terashima, Masanori, et al.
Publicado: (2017) -
Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer
por: Sasako, Mitsuru, et al.
Publicado: (2014) -
Erratum to: Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer
por: Sasako, Mitsuru, et al.
Publicado: (2014) -
Abnormal amphiregulin expression correlates with gastric cancer prognosis
por: Wang, Bing, et al.
Publicado: (2016) -
Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
por: Hisashige, Akinori, et al.
Publicado: (2013)